Thinking Post-COVID: How Will US FDA Transition Drug, Vaccine EUAs To Full Approvals?

Sponsors seek clarity about the transition process, which could last a year or longer.

Bike team pursuit
Many sponsors already are pursuing full approval of products now available through EUAs. • Source: Alamy

As calls increase to move beyond the coronavirus pandemic and return to normal life, sponsors are growing uneasy about the future of the drugs available under emergency use authorizations.

EUAs are intended to allow temporary use of a product during a public health emergency, but cannot remain available once the emergency officially ends. Products such as Pfizer Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Review Pathways

More from Pathways & Standards